PCA SKIN Intensive Clarity Treatment
NDC 68726-359, SALICYLIC ACID, gel, from CP Skin Health Group, Inc..
- Product NDC
- 68726-359
- Status
- Listed
- Labeler
- CP Skin Health Group, Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M006
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68726-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALICYLIC ACID2 g/100g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68726-359-02 | 68726035902 | 1 TUBE in 1 CARTON (68726-359-02) / 29.5 g in 1 TUBE (68726-359-01) |
| 68726-359-03 | 68726035903 | 2 g in 1 TUBE (68726-359-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68726-359 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68726-359 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68726-359. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.